| Name | Title | Contact Details |
|---|
Founded in 1981, Atrium is a diversified healthcare provider where improved patient outcomes is job one for every member of the firm. From Hudson, NH to Mosman (Sydney), Australia or Mijdrecht, The Netherlands, service and workmanship in the quality
Medical Plastic Device M P D is a Pointe-Claire, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RIEMSER is a Durham, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CryoLife`s mission is to partner with clinicians to restore health by delivering innovative technologies. CryoLife is one of the world`s leading medical device companies, providing preserved human tissues for cardiac and vascular surgeries, mechanical heart valves for aortic or mitral valve replacement, surgical adhesives and sealants, vascular grafts, and state-of-the-art technology and surgical training in adult and pediatric cardiovascular surgery. CryoLife is a pioneer and leader in processing, preserving and distributing human tissues, for use in cardiac and vascular surgeries. Founded in 1984, CryoLife was the first biomedical company to specialize in low temperature preservation of human heart valves used for complex cardiac reconstruction, primarily in children born with heart defects. Since the company`s inception, it is estimated that Cryolife has received tissues from over 145,000 donors and CryoLife products and tissues have been implanted in over 1 million patients worldwide. CryoLife is headquartered in Kennesaw, Georgia, with offices in Austin, Texas, Guildford, Surrey, UK, and Hechingen, Germany, as well as sales and marketing centers in Singapore, and representation in over 85 countries worldwide. The firm`s 1000+ employees hail from 11 countries and speak 17 languages. CryoLife`s staff includes numerous full-time physicians and Ph.D.s, with disciplines in chemical engineering, biomedical engineering, biochemistry, protein chemistry and organic chemistry. CryoLife is a public company and is traded on the New York Stock Exchange under the symbol CRY.
Orthofix Medical Inc. began in a small farmhouse in Verona Italy in 1980 when orthopedic researcher Giovanni De Bastiani recognized the bone`s natural repair capability, a concept he called “dynamization.” With that in mind, he created the first external fixation device. Today, Orthofix has grown to more than 1,200 employees with locations in the U.S., Italy, Germany, France, the U.K., Brazil, and Australia. Our products help patients in more than 70 countries around the world. The Company`s mission is to deliver innovative, quality-driven solutions as we partner with health care professionals to improve patient mobility. Headquartered in Lewisville, Texas, the company has two strategic business units: Spine and Orthopedics. Orthofix products are widely distributed via the company`s sales representatives and distributors. In addition, Orthofix is collaborating on research and development activities with leading clinical organizations such as MTF Biologics, the Orthopedic Research and Education Foundation, and the Texas Scottish Rite Hospital for Children. Orthofix makes a difference in the lives of others by providing our surgeon customers with innovative medical devices to meet the needs of their patients. Every day we are optimizing our operations, improving efficiencies, and examining our systems to provide the best support possible to our representatives, surgeons and patients.